**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
|----------------|--------------------------------------|----------|-----------|
| 88-12-0 |N-vinyl-2-pyrrolidone | 98 | 201-800-4 |
|----------------|--------------------------------------|----------|-----------|
| 1310-73-2 |Sodium hydroxide | 0.1 | 215-185-5 |
+----------------+--------------------------------------+----------+-----------+
Text for R-phrases: see Section 16
Hazard Symbols: XN
Risk Phrases: 20/21/22 37 40 41 48/20
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful by inhalation, in contact with skin and if swallowed.
Irritating to respiratory system. Limited evidence of a carcinogenic
effect. Risk of serious damage to eyes. Harmful : danger of serious
damage to health by prolonged exposure through inhalation.
Potential Health Effects
Eye:
Causes severe eye irritation. Causes redness and pain.
Skin:
May cause skin irritation. Harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. May cause nausea and
vomiting. May be harmful if swallowed.
Inhalation:
Causes respiratory tract irritation. May be harmful if inhaled. May
cause headache. Inhalation of vapors will cause coughing or
breathing difficulty.
Chronic:
Chronic exposure may cause liver damage. Chronic exposure may cause
lung damage.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
In case of contact, immediately flush eyes with plenty of water for
at least 15 minutes. Get medical aid immediately.
Skin:
In case of contact, immediately flush skin with plenty of water for
at least 15 minutes while removing contaminated clothing and shoes.
Get medical aid immediately. Wash clothing before reuse.
Ingestion:
If swallowed, do not induce vomiting unless directed to do so by
medical personnel. Never give anything by mouth to an unconscious
person. Get medical aid.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial
respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. Vapors may form an explosive mixture with air.
During a fire, irritating and highly toxic gases may be generated by
thermal decomposition or combustion. Will burn if involved in a fire.
Polymerizes readily if not inhibited; heat can initiate reaction.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth),
then place in suitable container. Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Use with adequate ventilation. Avoid breathing
vapor or mist. Do not get in eyes. Avoid contact with skin and
clothing.
Storage:
Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances. Store at
around 20C.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 88-12-0:
France - VME: 0.1 ppm VME
Germany: 0.1 ppm TWA; 0.5 mg/m3 TWA
Germany: Skin absorber
Russia: 1 mg/m3 TWA
CAS# 1310-73-2:
United Kingdom, WEL - STEL: 2 mg/m3 STEL
United States OSHA: 2 mg/m3 TWA
Belgium - TWA: 2 mg/m3 VLE
France - VME: 2 mg/m3 VME
Germany: 2 mg/m3 TWA (inhalable fraction)
Japan: 2 mg/m3 Ceiling
Malaysia: 2 mg/m3 Ceiling
Spain: 2 mg/m3 VLA-EC
Personal Protective Equipment
Eyes:
Wear chemical splash goggles.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Clear liquid
Color: colorless - yellow
Odor: characteristic odor
pH: 9-10(100g/l aq.sol.)
Vapor Pressure: 0.114 mm Hg @ 25 deg C
Viscosity: 2.4 mPa.s@ 20 deg C
Boiling Point: 90-92 deg C @ 13 mm Hg
Freezing/Melting Point: 13-14 deg C
Autoignition Temperature: Not available.
Flash Point: 95 deg C ( 203.00 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: Soluble.
Specific Gravity/Density: 1.0430g/cm3
Molecular Formula: C6H9NO
Molecular Weight: 111.14
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Becomes yellow over time. This material is a monomer and may
polymerize under certain conditions if the stabilizer is lost.
Conditions to Avoid:
Excess heat.
Incompatibilities with Other Materials:
Strong oxidizing agents, acids, polymerizing initiators.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide.
Hazardous Polymerization: May occur.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 88-12-0: UY6107000
CAS# 1310-73-2: WB4900000
LD50/LC50:
CAS# 88-12-0: Draize test, rabbit, eye: 100 mg Severe; Inhalation,
rat: LC50 = 3200 mg/m3/4H; Oral, rat: LD50 = 1470 mg/kg; Skin,
rabbit: LD50 = 560 mg/kg.
CAS# 1310-73-2: Draize test, rabbit, eye: 400 ug Mild; Draize test,
rabbit, eye: 1% Severe; Draize test, rabbit, eye: 50 ug/24H Severe;
Draize test, rabbit, eye: 1 mg/24H Severe; Draize test, rabbit,
skin: 500 mg/24H Severe.
Carcinogenicity:
N-vinyl-2-pyrrolidone -
ACGIH: A3 - Confirmed animal carcinogen with unknown relevance to
Sodium hydroxide -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
Ecotoxicity:
Log Pow 0.4
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: TOXIC LIQUID, ORGANIC, N.O.S.*
Hazard Class: 6.1
UN Number: 2810
Packing Group: III
IMO
Shipping Name: TOXIC LIQUID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2810
Packing Group: III
RID/ADR
Shipping Name: TOXIC LIQUID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2810
Packing group: III
USA RQ: CAS# 1310-73-2: 1000 lb final RQ; 454 kg final RQ
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 20/21/22 Harmful by inhalation, in contact with
skin and if swallowed.
R 37 Irritating to respiratory system.
R 40 Limited evidence of a carcinogenic effect.
R 41 Risk of serious damage to eyes.
R 48/20 Harmful : danger of serious damage to health
by prolonged exposure through inhalation.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
WGK (Water Danger/Protection)
CAS# 88-12-0: 3
CAS# 1310-73-2: 1
Canada
CAS# 88-12-0 is listed on Canada's DSL List.
CAS# 1310-73-2 is listed on Canada's DSL List.
CAS# 88-12-0 is listed on Canada's Ingredient Disclosure List.
CAS# 1310-73-2 is listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 88-12-0 is listed on the TSCA inventory.
CAS# 1310-73-2 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
Text for R-phrases from Section 2
R 35 Causes severe burns.
MSDS Creation Date: 8/21/1998 Revision #4 Date: 7/01/2002
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Aluminum isopropoxide
| 555-31-7 |
|
Cholesteryl-2-(ethoxyethoxy)ethyl Carbonate
| 15484-00-1 |
|
3,5-Lutidine, 98+%
| 591-22-0 |
|
Ethyl 4-Methoxyphenylacetate, 97+%
| 14062-18-1 |
|
(-)-Camphanic acid, 99%
| 13429-83-9 |
|
Amberlite irc-718 ion-exchange resin
| 79620-28-3 |
|
3,4,5-Trifluoroaniline, 98%
| |
|
Carbobenzyloxy-D-Phenylalanine, 99+%
| 28709-70-8 |
|
DL-Thioctic Acid, 98% (UV, on the Dried Substance)
| 1077-28-7 |
|
Dowex 1x2-200 ion-exchange resin
| 9085-42-1 |
|
Diphenylacetylchloride, 97.5%
| 1871-76-7 |
|
4-Methyl-1-pentene, 97%
| 691-37-2 |
|
Ethylmethacrylate, 99% (GC)
| 97-63-2 |
|
Anthraquinone-1,5-disulfonic acid, disodium salt, hydrate, tech.
| 853-35-0 |
|
Copper atomic absorption standard solution, 1 mg/ml Cu in 2% HNO3
| 7440-50-8 |
|
Gadolinium (iii) nitrate pentahydrate 99.999%
| 52788-53-1 |
|
1-Iodononane, 99%
| 4282-42-2 |
|
Isopulegol, tech
| 89-79-2 |
|
5-Chloro-8-Hydroxyquinoline, 95%
| 130-16-5 |
|
4-Amino-1-naphthalenesulfonic acid, sodium salt, hydrate, 98%
| 130-13-2 |
|
1,3,5-Trichlorobenzene, 99%
| 108-70-3 |
|
Indoline, 99%
| 496-15-1 |
|
Dimethylamino-1-Naphthylisothiocyanate, 98%
| 29711-79-3 |
|
DL-Alanine Ethyl Ester Hydrochloride, 99% (Titr.)
| 617-27-6 |
|
N-Vinyl-2-pyrrolidinone, stabilized, 98%
| 88-12-0 |
|
Dowex 50x4-400 ion-exchange resin
| 11113-61-4 |
|
Dibutyltin dichloride, 97%
| 683-18-1 |
|
Butyl 4-(4-ethoxyphenoxycarbonyl)phenyl carbonate
| 16494-24-9 |
|
Dihydrocoumarin, 99%
| 119-84-6 |
|
3-Methylbenzyl Cyanide, 98%
| 2947-60-6 |
|
2-Methyl-2-pentene, 99+%
| 625-27-4 |
|
1-Amino-4-methylpiperazine dihydrochloride, monohydrate, 98%
| 40675-60-3 |
|
Bromothymol Blue, Reagent ACS, 97% (uv-vis )
| 76-59-5 |
|
1-(beta-Phenethyl)-4-piperidone, 98%
| 39742-60-4 |
|
2-Ethylfuran, 99%
| 3208-16-0 |
|
Aniline sulfate, 99% (uv-vis)
| 542-16-5 |
|
1-Chloro-2-Propanol, 70%, Remainder 2-Chloro-1-Propanol
| 127-00-4 |
|
Metronidazole, 99%
| 443-48-1 |
|
Tetrabromothiophene, 99+%
| 3958-03-0 |
|
2-(4-Chlorophenoxy)-2-Methylpropionic Acid, 99%
| 882-09-7 |
|
N,N-Dimethylethylamine, 99%
| 598-56-1 |
|
4-Formylphenoxyacetic acid, 99% (titr.)
| 22042-71-3 |
|
1-Amino-2-Naphthol Hydrochloride, Tech., 90%
| 1198-27-2 |
|
N-Acetylmorpholine, 98%
| 1696-20-4 |
|
3-Phenylpropylacetate,98+% (gc)
| 122-72-5 |
|
Europium(iii) chloride hexahydrate, 99.99%
| 13759-92-7 |
|
1,1,3-Trimethoxypropane, 99%
| 14315-97-0 |
|
2-Amino-4-Imino-2-Thiazoline Hydrochloride, 99%
| 36518-76-0 |
|
3-Chlorobenzyl cyanide, 99%
| 1529-41-5 |
|
Tetraphenylethylene, 98%
| 632-51-9 |
|
|